Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.

Jonathan V MuiLifang LiOscar Hou-In ChouNida AzfarAthena LeeJeremy HuiSharen LeeGary TseJiandong Zhou

Published in: Acta diabetologica (2023)

SGLT2I use is associated with significantly lower risk of depression compared to DPP4 use in T2DM patients using propensity score matching and Cox regression analyses.

Keyphrases

end stage renal disease
chronic kidney disease
depressive symptoms
newly diagnosed
ejection fraction
prognostic factors
sleep quality
physical activity
patient reported outcomes
patient reported
insulin resistance